At its March 8, 2022, meeting, the Board approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research (CER) and methods studies, and three projects to facilitate implementation of PCORI-funded research findings in the treatment of urinary incontinence, care of patients with sickle cell disease, and mental health care.
The Board also approved development of two new PCORI Funding Announcements (PFAs)—one on health systems strategies to reduce disparities in hypertension management and control and the other on building an evidence base to stakeholder engagement in patient-centered CER. In addition, the Board adopted a new Research Agenda, which will help in outlining how PCORI will focus its patient-centered CER funding and other activities in the years ahead.
The Board also approved PCORI's provision of $25 million to support the second phase of the Learning Health Systems Training Program, and received an overview about PCORI's work on maternal morbidity and mortality—a priority area for PCORI funding—from Executive Director Nakela L. Cook, MD, MPH.
Approved Minutes of the March 2022 Board Meeting
Public Comment Period
This Board meeting included a public comment period and registration^ was required to provide comments via telephone. (Guidelines for Public Comments) (Technical Guidance for Commenters) There were no requests to provide comments during this meeting.
All PCORI Board meetings are open to the public. This Board meeting was held virtually via teleconference/webinar and registration was required. Catch up on past PCORI Board meetings here.
^Please note that after you sign up to provide comment, you will receive a confirmation email from PCORI. Please check your spam folder for this email if you don’t receive it and reply to the email to confirm your intention to make a public comment.